Redpoint Investment Management’s AbbVie ABBV Stock Holding History

Redpoint Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5.18M	Sell	38,632 -5,399	-12%	-$775K	0.76%	20
2022 Q2	$6.74M	Hold	44,031	–	–	0.8%	18
2022 Q1	$7.14M	Sell	44,031 -735	-2%	-$107K	0.71%	18
2021 Q4	$6.06M	Sell	44,766 -397	-0.9%	-$46.9K	0.48%	39
2021 Q3	$4.87M	Sell	45,163 -1,495	-3%	-$171K	0.42%	56
2021 Q2	$5.26M	Hold	46,658	–	–	0.43%	49
2021 Q1	$5.05M	Buy	+46,658	New	+$4.99M	0.43%	52
2020 Q4	–	Sell	-42,834	Closed	-$3.75M	–	572
2020 Q3	$3.75M	Sell	42,834 -68,022	-61%	-$6.4M	0.4%	60
2020 Q2	$10.9M	Buy	110,856 +7,525	+7%	+$663K	0.6%	30
2020 Q1	$7.87M	Hold	103,331	–	–	0.49%	48
2019 Q4	$9.15M	Sell	103,331 -864	-0.8%	-$71.7K	0.45%	44
2019 Q3	$7.89M	Sell	104,195 -6,321	-6%	-$433K	0.42%	52
2019 Q2	$8.04M	Sell	110,516 -6,083	-5%	-$478K	0.42%	49
2019 Q1	$9.4M	Buy	116,599 +907	+0.8%	+$74.2K	0.47%	44
2018 Q4	$10.7M	Sell	115,692 -6,876	-6%	-$605K	0.62%	34
2018 Q3	$11.6M	Buy	122,568 +1,615	+1%	+$153K	0.59%	34
2018 Q2	$11.2M	Sell	120,953 -1,064	-0.9%	-$104K	0.61%	33
2018 Q1	$11.5M	Buy	122,017 +603	+0.5%	+$66.2K	0.64%	31
2017 Q4	$11.7M	Buy	+121,414	New	+$11.4M	0.65%	31

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redpoint Investment Management's ABBV Position: Q3 2022 in Review

Redpoint Investment Management reduced its AbbVie (ABBV) stake by 12% in Q3 2022, selling an estimated $775K and leaving 38,632 shares worth $5.18M. The position accounts for 0.76% of the portfolio, ranked #20.

Redpoint Investment Management first reported a position in ABBV in Q4 2017 and has held it in 19 quarters since. The position peaked at $11.7M in Q4 2017. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

Redpoint Investment Management held 38,632 shares of AbbVie worth $5.18M as of Q3 2022.
Redpoint Investment Management sold 5,399 AbbVie shares in Q3 2022, an estimated $775K.
AbbVie made up 0.76% of Redpoint Investment Management's portfolio in Q3 2022, its #20 holding.
Redpoint Investment Management first reported a position in AbbVie in Q4 2017 and has held it in 19 quarters since.
Redpoint Investment Management's AbbVie position peaked at $11.7M in Q4 2017.
2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.